Evidence map›Paper›PMID 18674747›Full record

ArticleAmerican journal of human genetics2008

Pathogenic mitochondrial DNA mutations are common in the general population.

Hannah R Elliott, David C Samuels, James A Eden, Caroline L Relton, Patrick F Chinnery

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 271 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
271citing papers in PubMed, 2 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06080581 completednot on this mapstarted 2023, after this paper: background citation

Mitochondrial Derangements Driving Muscle Insulin Resistance in Humans

TypeobservationalSponsorRigshospitalet, DenmarkRan2023 to 2024Enrolled30ConditionsMitochondrial Myopathies, Mitochondrial Diseases, Mitochondrial Disorders
NCT06080594 nacompletednot on this mapstarted 2024, after this paper: background citation

Exercise-mediated Rescue of Mitochondrial Derangements Driving Insulin Resistance in Humans (EX-MITO-DYS-IR)

TypeinterventionalSponsorRigshospitalet, DenmarkRan2024 to 2025Enrolled11ConditionsMitochondrial Myopathies, Mitochondrial Diseases, Mitochondrial DisordersArmsHigh-intensity exercise training
3 · Its place in the literature

Who cites it

271 citing papers in PubMed, 2 syntheses or guidelines pooled it, 601 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Mitochondrial tRNA-Derived Diseases.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Cardiac magnetic resonance findings in mitochondrial disease: a guide for clinicians.European heart journal. Imaging methods and practice · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Advances in Management of Mitochondrial Myopathies.International journal of molecular sciences · 2025
    Review
  17. Review
  18. Review
  19. Review
  20. Review

211 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hannah R ElliottMitochondrial Research Group, Newcastle University, Newcastle upon Tyne, UK.
David C Samuels
James A Eden
Caroline L Relton
Patrick F Chinnery
Newcastle University · GBVirginia Tech · USWellcome Centre for Mitochondrial Research · GB

Funding

Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

Mitochondrial DNA (mtDNA) mutations are a major cause of genetic disease, but their prevalence in the general population is not known. We determined the frequency of ten mitochondrial point mutations in 3168 neonatal-cord-blood samples from sequential live births, analyzing matched maternal-blood samples to estimate the de novo mutation rate. mtDNA mutations were detected in 15 offspring (0.54%, 95% CI = 0.30-0.89%). Of these live births, 0.00107% (95% CI = 0.00087-0.0127) harbored a mutation not detected in the mother's blood, providing an estimate of the de novo mutation rate. The most common mutation was m.3243A-->G. m.14484T-->C was only found on sub-branches of mtDNA haplogroup J. In conclusion, at least one in 200 healthy humans harbors a pathogenic mtDNA mutation that potentially causes disease in the offspring of female carriers. The exclusive detection of m.14484T-->C on haplogroup J implicates the background mtDNA haplotype in mutagenesis. These findings emphasize the importance of developing new approaches to prevent transmission.

Indexed as

DNA Mutational AnalysisMutationCohort StudiesDNA, MitochondrialFemaleFetal BloodGenetics, PopulationGenotypeHaplotypesHeterozygoteHumansMitochondrial DiseasesModels, GeneticModels, StatisticalPrevalenceDNA, Mitochondrial

Identifiers

PMID18674747
PMCPMC2495064
OpenAlexW1967511612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.